In This Store
Hangzhou Jinlan Pharm-Drugs Technology Co., Ltd. (JL Pharm) is established in 2012 at the beautiful West Lake – Hangzhou city, China. The company's main business includes R&D, Production and Sales of Formulation, APIs, and intermediates. The company's main products include API, Contrast Media, related formulation, intermediates, and new product development.
Our main business focus on:
Our main products includes:
Sofosbuvir, Velpatasvir, Glecaprevir, Pibrentasvir, Tenofovir disoproxil fumarate, TDF, Tenofovir Alafenamide, Entecavir, Darunavir,
Semaglutide, Tirzepatide, Liraglutide, Retatrutide, Orforglipron, Lixisenatide, Dulaglutide, Insulin Detemir, Insulin Glargine, Insulin Aspart, Insulin Lispro, Insulin Degludec,
Oseltamivir phosphate, Moxifloxacin HCl, Baloxavir Marboxil, Peremivir, Tecovirimat and so on.
Year of Establishment: 2012
Total Assets(USD):
Total Number of Staff:
Main Competitive Advantages: Brand Name,International Approvals/Standards,Experienced R&D Staff,Contract Manufacturing (CRO,CMO),Buyers' Specifications Accepted,Small Orders Accepted,Reputation,Quality Service
Other Competitive Advantages:
Patents and Copyrights:
Contact Us
Tel: (+86) 400 610 1188
WhatsApp/Telegram/Wechat: +86 13621645194
Follow Us: